Smith, Moore & Co. Abbott Laboratories Transaction History

Smith, Moore & Co.

$1.03 Billion
Q3 2024

A detailed history of Smith, Moore & Co. transactions in Abbott Laboratories stock. As of the latest transaction made, Smith, Moore & Co. holds 26,598 shares of ABT stock, worth $3.08 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

26,598

Previous 26,821 0.83%

Holding current value

$3.08 Million

Previous $2.79 Million 8.83%

% of portfolio

0.29%

Previous 0.29%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $22,315 - $26,342	-223 Reduced 0.83%	26,598 $3.03 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $31,327 - $34,968	-311 Reduced 1.15%	26,821 $2.79 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $55,855 - $61,689	-510 Reduced 1.85%	27,132 $3.08 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $121,395 - $148,598	-1,346 Reduced 4.64%	27,642 $3.04 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $47,287 - $56,736	495 Added 1.74%	28,988 $2.81 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $17,031 - $18,977	-169 Reduced 0.59%	28,493 $3.11 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $40,584 - $47,770	419 Added 1.48%	28,662 $2.9 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $20,532 - $24,088	-216 Reduced 0.76%	28,243 $3.1 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $47,896 - $55,454	-495 Reduced 1.71%	28,459 $2.75 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $70,020 - $84,631	-686 Reduced 2.31%	28,954 $3.15 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $116,186 - $141,681	1,019 Added 3.56%	29,640 $3.51 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $26,109 - $31,969	-226 Reduced 0.78%	28,621 $4.03 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $16,799 - $18,584	-144 Reduced 0.5%	28,847 $3.41 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $26,976 - $31,755	255 Added 0.89%	28,991 $3.4 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $117,982 - $139,001	1,084 Added 3.92%	28,736 $3.44 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $261,135 - $284,562	-2,487 Reduced 8.25%	27,652 $2.99 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $54,800 - $66,551	598 Added 2.02%	30,139 $3.28 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $30,398 - $38,906	-397 Reduced 1.33%	29,541 $2.67 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $32,415 - $47,399	-516 Reduced 1.69%	29,938 $2.36 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $78 - $87	-1 Reduced -0.0%	30,454 $2.65 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $272,854 - $295,859	-3,334 Reduced 9.87%	30,455 $2.55 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $39,938 - $46,580	-548 Reduced 1.6%	33,789 $2.84 Million
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $212,433 - $256,832	-3,208 Reduced 8.54%	34,337 $2.78 Million
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $14,488 - $16,413	-221 Reduced 0.59%	37,545 $2.72 Million
Q3 2018 Nov 15, 2018	BUY	$60.81 - $73.36 $194,166 - $234,238	3,193 Added 9.24%	37,766 $2.8 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $30,339 - $33,485	-527 Reduced 1.5%	34,573 $2.11 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $153,054 - $173,046	-2,720 Reduced 7.19%	35,100 $2.1 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $156,047 - $167,065	2,907 Added 8.33%	37,820 $2.16 Million
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $1.68 Million - $1.87 Million	34,913	34,913 $1.86 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account